These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28811537)

  • 1. Prognostic significance and function of mammalian target of rapamycin in tongue squamous cell carcinoma.
    Li SH; Chien CY; Huang WT; Luo SD; Su YY; Tien WY; Lan YC; Chen CH
    Sci Rep; 2017 Aug; 7(1):8178. PubMed ID: 28811537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma.
    Li SH; Chen CH; Lu HI; Huang WT; Tien WY; Lan YC; Lee CC; Chen YH; Huang HY; Chang AY; Lin WC
    Surgery; 2015 Mar; 157(3):570-80. PubMed ID: 25726316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation.
    Li SH; Lu HI; Chang AY; Huang WT; Lin WC; Lee CC; Tien WY; Lan YC; Tsai HT; Chen CH
    Oncotarget; 2016 Oct; 7(41):67150-67165. PubMed ID: 27564102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic significance and function of mammalian target of rapamycin activation in esophageal squamous cell carcinoma.
    Kim SH; Chau GC; Jang YH; Lee SI; Pyo S; Um SH
    Hum Pathol; 2013 Feb; 44(2):226-36. PubMed ID: 22944293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
    Histopathology; 2011 Sep; 59(3):514-25. PubMed ID: 22034891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
    Theocharis S; Giaginis C; Alexandrou P; Rodriguez J; Tasoulas J; Danas E; Patsouris E; Klijanienko J
    Tumour Biol; 2016 Mar; 37(3):3647-56. PubMed ID: 26459312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated mTOR expression correlates with podoplanin expression and high tumor grade in esophageal squamous cell carcinoma.
    Chuang WY; Chang YS; Chao YK; Yeh CJ; Ueng SH; Chang CY; Liu YH; Tseng CK; Chang HK; Wan YL; Hsueh C
    Int J Clin Exp Pathol; 2015; 8(10):12757-65. PubMed ID: 26722465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial assembly receptor expression is an independent prognosticator for patients with oral tongue squamous cell carcinoma.
    Su YY; Chen CH; Chien CY; Lin WC; Huang WT; Li SH
    J Renin Angiotensin Aldosterone Syst; 2017; 18(3):1470320317717904. PubMed ID: 28747140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3-kinase pathway biomarkers in oral cancer and tumor immune cells.
    Ibrahim MY; Nunez MI; Harun N; Lee JJ; El-Naggar AK; Ferrarotto R; Wistuba I; Myers J; Glisson BS; William WN
    Head Neck; 2019 Mar; 41(3):615-622. PubMed ID: 30556200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
    Endo K; Shirai A; Furukawa M; Yoshizaki T
    Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.
    Li J; Huang H; Sun L; Yang M; Pan C; Chen W; Wu D; Lin Z; Zeng C; Yao Y; Zhang P; Song E
    Clin Cancer Res; 2009 Jun; 15(12):3998-4008. PubMed ID: 19509158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian target of rapamycin expression and laryngeal squamous cell carcinoma prognosis: novel preliminary evidence.
    Marioni G; Staffieri A; Giacomelli L; Lionello M; Guzzardo V; Busnardo A; Blandamura S
    Histopathology; 2011 Jun; 58(7):1148-56. PubMed ID: 21707714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma.
    Rusthoven K; Ballonoff A; Raben D; Chen C
    Cancer; 2008 Jan; 112(2):345-51. PubMed ID: 18041071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases.
    Ling W; Mijiti A; Moming A
    J Oral Maxillofac Surg; 2013 Apr; 71(4):775-85. PubMed ID: 23265849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Satre-Garau X
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):251-9. PubMed ID: 20390425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular interleukin-17F has a protective effect in oral tongue squamous cell carcinoma.
    Almahmoudi R; Salem A; Sieviläinen M; Sundquist E; Almangush A; Toppila-Salmi S; Paavonen T; Salo T; Al-Samadi A
    Head Neck; 2018 Oct; 40(10):2155-2165. PubMed ID: 29761594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of hypoxia markers in T2-staged oral tongue cancer.
    Roh JL; Cho KJ; Kwon GY; Ryu CH; Chang HW; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Jan; 45(1):63-8. PubMed ID: 18620902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White adipose tissue inflammation and cancer-specific survival in patients with squamous cell carcinoma of the oral tongue.
    Iyengar NM; Ghossein RA; Morris LG; Zhou XK; Kochhar A; Morris PG; Pfister DG; Patel SG; Boyle JO; Hudis CA; Dannenberg AJ
    Cancer; 2016 Dec; 122(24):3794-3802. PubMed ID: 27508351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of clinical, histological, and cytokeratin profiles of squamous cell carcinoma of the oral tongue with prognosis.
    Silveira EJ; Godoy GP; Lins RD; Arruda Mde L; Ramos CC; Freitas Rde A; Queiroz LM
    Int J Surg Pathol; 2007 Oct; 15(4):376-83. PubMed ID: 17913944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.